2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome, Yi Heng Li, Yu Chen Wang, Yi Chih Wang, Ju Chi Liu, Cheng Han Lee, Chun Chi Chen, I. Chang Hsieh, Feng You Kuo, Wei Chun Huang, Shih Hsien Sung, Chiung Zuan Chiu, Jung Cheng Hsu, Shu Long Jen, Juey Jen Hwang, Jiunn Lee Lin

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

LanguageEnglish
Pages766-790
Number of pages25
JournalJournal of the Formosan Medical Association
Volume117
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Emergency Medicine
Acute Coronary Syndrome
Cardiology
Taiwan
Guidelines
Troponin
Percutaneous Coronary Intervention
Therapeutics
Coronary Angiography
Coronary Artery Bypass
Physical Examination
Anatomy
History
Delivery of Health Care
Incidence

Keywords

  • Acute coronary syndrome
  • Guideline
  • Taiwan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. / The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome.

In: Journal of the Formosan Medical Association, Vol. 117, No. 9, 01.09.2018, p. 766-790.

Research output: Contribution to journalArticle

@article{592ca47bc8604a0c873ecf077524148e,
title = "2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome",
abstract = "In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.",
keywords = "Acute coronary syndrome, Guideline, Taiwan",
author = "{The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome} and Li, {Yi Heng} and Wang, {Yu Chen} and Wang, {Yi Chih} and Liu, {Ju Chi} and Lee, {Cheng Han} and Chen, {Chun Chi} and Hsieh, {I. Chang} and Kuo, {Feng You} and Huang, {Wei Chun} and Sung, {Shih Hsien} and Chiu, {Chiung Zuan} and Hsu, {Jung Cheng} and Jen, {Shu Long} and Hwang, {Juey Jen} and Lin, {Jiunn Lee}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jfma.2018.06.002",
language = "English",
volume = "117",
pages = "766--790",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

AU - The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome

AU - Li, Yi Heng

AU - Wang, Yu Chen

AU - Wang, Yi Chih

AU - Liu, Ju Chi

AU - Lee, Cheng Han

AU - Chen, Chun Chi

AU - Hsieh, I. Chang

AU - Kuo, Feng You

AU - Huang, Wei Chun

AU - Sung, Shih Hsien

AU - Chiu, Chiung Zuan

AU - Hsu, Jung Cheng

AU - Jen, Shu Long

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

PY - 2018/9/1

Y1 - 2018/9/1

N2 - In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

AB - In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

KW - Acute coronary syndrome

KW - Guideline

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=85049739967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049739967&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2018.06.002

DO - 10.1016/j.jfma.2018.06.002

M3 - Article

VL - 117

SP - 766

EP - 790

JO - Journal of the Formosan Medical Association

T2 - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 9

ER -